Santhera Pharmaceuticals Holding AG
(XSWX:SANN)
CHF
8.25
-0.14 (-1.67%)
Market Cap: 93.39 Mil
Enterprise Value: 84.57 Mil
PE Ratio: 1.65
PB Ratio: 1.56
GF Score: 41/100 Santhera Pharmaceuticals Holding AG (XSWX:SANN) Transcripts
- Full Year 2023 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 25, 2024CHF9.5 (+0.42%)Earnings
- Santhera Pharmaceuticals Holding AG at HC Wainwright Investment Conference - New York TranscriptSep 12, 2023
- Santhera Pharmaceuticals Holding AG To Discuss The Agreement on Vamorolone TranscriptJun 20, 2023
- Full Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 27, 2023CHF6.3 (-8.70%)Earnings
- Half Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptNov 07, 2022CHF5.84 (-1.02%)Earnings
- Full Year 2021 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptJun 10, 2022CHF10.6 (+0.76%)Earnings
- Santhera Pharmaceuticals Holding AG Investor Conference Call - Looking Ahead to 2022 TranscriptDec 08, 2021
- Q2 2021 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptSep 22, 2021CHF14.8 (-1.86%)Earnings
- Q4 2020 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 29, 2021CHF26.3 (-7.88%)Earnings
- 1